Search

everythinglearnresearchcommunity

for

Search:↓

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Adrenal glands delay the start of winter fur growth in mink.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

South Asian women with PCOS are more likely to have metabolic issues and central obesity, and simple measures like waist size and blood pressure can help identify these risks early.

Lowering testosterone speeds up wound healing in male mice.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Early balding men may have insulin resistance, but lifestyle changes can help.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Acne is an important sign of androgen excess disorders in women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.